Table 2 Physical exam: clinical manifestations and vitals signs
No Match | Match | |||||||
|---|---|---|---|---|---|---|---|---|
Total population n= 505 | Rivaroxaban n= 220 | Warfarin n= 285 | p value | Total population n= 418 | Rivaroxaban n= 209 | Warfarin n= 209 | p value | |
Dyspnoea, n(%) | 149 (29.5) | 63 (28.6) | 86 (30.2) | 0.71 | 122 (29.2) | 58 (27.8) | 64 (30.6) | 0.52 |
Chest pain, n(%) | 159 (31.5) | 61 (27.7) | 98 (34.4) | 0.11 | 129 (30.9) | 57 (27.3) | 72 (34.4) | 0.11 |
Hemoptisis, n(%) | 21 (4.2) | 6 (2.7) | 15 (5.3) | 0.16 | 18 (4.3) | 6 (2.9) | 12 (5.7) | 0.15 |
Unilateral lower limb pain, n(%) | 264 (52.3) | 114 (51.8) | 150 (52.6) | 0.86 | 216 (51.7) | 109 (52.2) | 107 (51.2) | 0.84 |
Unilateral lower limb edema, n(%) | 264 (52.3) | 113 (51.4) | 151 (53) | 0.72 | 216 (51.7) | 108 (51.7) | 108 (51.7) | 1.00 |
Lower limb pain on palpation, n(%) | 228 (45.1) | 97 (44.1) | 131 (46) | 0.67 | 188 (45) | 92 (44) | 96 (45.9) | 0.69 |
Non-varicose collateral veins, n(%) | 8 (1.6) | 3 (1.4) | 5 (1.8) | 0.73 | 5 (1.2) | 2 (1) | 3 (1.4) | 0.65 |
VD in the lower limbs, n(%) | 21 (4.2) | 7 (3.2) | 14 (4.9) | 0.33 | 16 (3.8) | 7 (3.3) | 9 (4.3) | 0.61 |
DD of lower limbs >3cm, n(%) | 84 (16.6) | 32 (14.5) | 52 (18.2) | 0.27 | 70 (16.7) | 32 (15.3) | 38 (18.2) | 0.43 |
Temperature, m(SD) | 36.2 (3.21) | 36.3 (2.49) | 36.1 (3.66) | 0.64 | 36.2 (3.06) | 36.2 (2.56) | 36.2 (3.49) | 0.75 |
Systolic blood pressure, m(SD) | 126.6 (18.88) | 127.7 (19.02) | 125.7 (18.76) | 0.24 | 127.2 (18.76) | 127.3 (18.57) | 127.1 (18.98) | 0.93 |
Diastolic blood pressure, m(SD) | 75.6 (11.85) | 75.5 (11.91) | 75.7 (11.81) | 0.83 | 75.8 (11.51) | 75.4 (11.62) | 76.2 (11.42) | 0.48 |
Heart rate, m(SD) | 85.8 (16.16) | 85.3 (15.67) | 86.2 (16.54) | 0.52 | 85.9 (15.83) | 85.4 (15.95) | 86.4 (15.72) | 0.51 |
Oxygen saturation, m(SD) | 91.1 (7.68) | 90.7 (8.13) | 91.4 (7.32) | 0.35 | 91 (6.95) | 90.7 (8.32) | 91.3 (5.27) | 0.36 |